Tissue Engineering Technique Gets FDA Nod

The US Food and Drug Administration approves a device, seeded with a patient’s own cells, which can help repair damaged knee cartilage—a first for autologous cartilage technology.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, JAMES HEILMANThe US Food and Drug Administration (FDA) this week (December 15) approved “Maci,” a tissue engineering technique that involves growing a patients’ own cartilage on scaffolds and then implanting the cell-covered device back into their damaged knees. The announcement comes on the heels of a promising two-year trial followed by a similarly successful three-year study, MedPage Today reported, which demonstrated safety and efficacy in 144 patients. “Overall efficacy data support a long-term clinical benefit from the use of the Maci implant in patients with cartilage defects,” the FDA wrote in a release.

The surgical technique involves expanding the patient’s autologous cartilage cells and then growing them within a porcine-derived collagen membrane, which can then be implanted back into the patient’s knee, even more than once (if needed). Surgeons interested in using Maci, which is manufactured by Cambridge, Massachusetts-based Vericel Corporation, will require specific training in the technique.

“Different cartilage defects require different treatments, so therapy must be tailored to the patient,” said Celia Witten, deputy director of the FDA’s Center for Biologics Evaluation and Research, in the release.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Joshua A. Krisch

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide